Indivior PLC INDV-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 4:35 PM GMT
218.80quote price arrow down-3.60 (-1.62%)
52 week range
93.70 - 265.33
Loading...
  • Open218.80
  • Day High225.20
  • Day Low217.00
  • Prev Close222.40
  • 52 Week High265.33
  • 52 Week High Date11/04/21
  • 52 Week Low93.70
  • 52 Week Low Date12/22/20

Key Stats

  • Market Cap2,243.54M
  • Shares Out733.5M
  • 10 Day Average Volume2.45M
  • Dividend-
  • Dividend Yield-
  • Beta-0.87
  • YTD % Change101.1

KEY STATS

  • Open218.80
  • Day High225.20
  • Day Low217.00
  • Prev Close222.40
  • 52 Week High265.33
  • 52 Week High Date11/04/21
  • 52 Week Low93.70
  • 52 Week Low Date12/22/20
  • Market Cap2,243.54M
  • Shares Out733.5M
  • 10 Day Average Volume2.45M
  • Dividend-
  • Dividend Yield-
  • Beta-0.87
  • YTD % Change101.1

RATIOS/PROFITABILITY

  • EPS (TTM)15.77
  • P/E (TTM)13.87
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date06/16/2016
  • Div Amount7.30
  • Split Date-
  • Split Factor-

Latest On Indivior PLC

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Indivior PLC (Indivior) is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence (the Indivior Business). Its treatment and pipeline focus is opioid use disorder, alcohol use disorder, overdose rescue and central nervous system (CNS) disorders/schizophrenia. Its products are Suboxone Film (buprenorphine and naloxone), Suboxone Tablet (buprenorphine...
Graham Hetherington
Non-Executive Chairman
Mark Crossley
Chief Executive Officer
Ryan Preblick
Chief Financial Officer
Address
234 Bath Road
Slough
SL1 4EE
United Kingdom